Nicholas S. Moore

Clinical interpretation of integrative molecular profiles to guide precision cancer medicine

E. V. Van Allen, K. Mouw, F. Dietlein, 2020, bioRxiv.

Prioritizing Germline and Somatic Variants for Precision Oncology

Nathanael D. Moore, E. Allen, B. Reardon, 2022 .

Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology

Nathanael D. Moore, E. V. Van Allen, K. Mouw, 2021, Nature Cancer.

Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma

Ryan L. Collins, E. V. Van Allen, T. Choueiri, 2023, medRxiv.

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma

E. V. Van Allen, T. Callis, T. Choueiri, 2019, Genetics in Medicine.

Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.

E. V. Van Allen, A. Taylor-Weiner, K. Salari, 2020, JAMA.

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma

E. V. Van Allen, T. Callis, T. Choueiri, 2019, Genetics in Medicine.